Literature DB >> 4037752

Ganglioside patterns in amyotrophic lateral sclerosis brain regions.

M M Rapport, H Donnenfeld, W Brunner, B Hungund, H Bartfeld.   

Abstract

In a search for evidence of biochemical disorders in regions of postmortem brain other than the motor cortex in amyotrophic lateral sclerosis (ALS), ganglioside patterns were also examined in the frontal, temporal, and parahippocampal gyrus cortex. In 21 ALS brains studied (20 sporadic, 1 familial), abnormal patterns were found in the frontal cortex (81%), temporal cortex (75%), motor cortex (70%), and parahippocampal gyrus cortex (71%). Patterns were established by measuring the percentage distribution of 12 ganglioside species. Two abnormal patterns were detected. One was based on low proportions of GD1b, GT1b, and GQ1b associated with high proportions of GM2 and GD3 (GM1, GD1a, GD2, and GT1a values were normal). The second abnormality was the appearance of Gx. Neither abnormality was seen in the 13 non-ALS control brains. The first, and predominant, abnormality was found in the frontal cortex in 14 brains, and the second was observed in 13 brains; 10 brains showed both abnormalities. These findings thus constitute evidence that the disease process in ALS extends beyond the motor cortex and involves neurons in several brain areas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037752     DOI: 10.1002/ana.410180111

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

Review 1.  Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells.

Authors:  Yutaka Itokazu; Yi-Tzang Tsai; Robert K Yu
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

2.  Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.

Authors:  James C Dodge; Christopher M Treleaven; Joshua Pacheco; Samantha Cooper; Channa Bao; Marissa Abraham; Mandy Cromwell; S Pablo Sardi; Wei-Lien Chuang; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

3.  One-pot multienzyme (OPME) chemoenzymatic synthesis of brain ganglioside glycans with human ST3GAL II expressed in E. coli.

Authors:  Xiaoxiao Yang; Hai Yu; Xiaohong Yang; Anoopjit Singh Kooner; Yue Yuan; Bryant Luu; Xi Chen
Journal:  ChemCatChem       Date:  2021-11-29       Impact factor: 5.497

4.  New Insights on Non-Enzymatic Oxidation of Ganglioside GM1 Using Mass Spectrometry.

Authors:  Daniela Couto; Tânia Melo; Elisabete Maciel; Ana Campos; Eliana Alves; Sofia Guedes; M Rosário M Domingues; Pedro Domingues
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-30       Impact factor: 3.109

5.  A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

Authors:  A Stevens; M Weller; H Wiethölter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

6.  Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS.

Authors:  Arseny Finkelstein; Gilad Kunis; Akop Seksenyan; Ayal Ronen; Tamara Berkutzki; David Azoulay; Maya Koronyo-Hamaoui; Michal Schwartz
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

7.  Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration.

Authors:  Anandh Dhanushkodi; Michael P McDonald
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

8.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

9.  Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Alexandre Henriques; Mylene Huebecker; Hélène Blasco; Céline Keime; Christian R Andres; Philippe Corcia; David A Priestman; Frances M Platt; Michael Spedding; Jean-Philippe Loeffler
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

Review 10.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.